Salute e Benessere

Education Cannot Wait and Special Olympics International Join Forces to Advance…

This collaboration will tackle educational barriers faced by children and youth with intellectual disabilities through sports programming in emergency and protracted crisis settings. This collaboration will tackle educational barriers faced by children and youth with intellectual disabilities through sports programming in emergency and protracted crisis settings. Through its Acceleration Facility, ECW will support SOI to expand the Special Olympics Unified Champion Schools® programme,...
PR Newswire
03/12/2024

CLAIRE'S CONTINUES MOMENTUM IN BEAUTY WITH THE INTRODUCTION OF C BY CLAIRE'S

The new collection features luxurious foaming moisturisers, bath and body scrubs, fragrances, hair and body mists, and more, meeting consumers' demands for beauty products that help them feel empowered in the same way that the brand's signature fashion accessories have for over 50 years. C by Claire's is crafted with high-quality ingredients in delightful, original scents like Cherry Bliss, Cloudberry Fizz, Watermelon Kiss, and Salted Caramel, with many catering to the growing gourmand scent…
PR Newswire
03/12/2024

Sobi's strength in haematology to be showcased at ASH 2024

Key data to be presented at ASH 2024 Key data to be presented at ASH 2024 Session date: Monday, December 9, 2024, 10:30 AM - 12:00 PM Presentation time: 11:30 AM Session date: Monday, December 9, 2024, 10:30 AM - 12:00 PM Presentation time: 11:00 AM Session date: Saturday, December 7, 2024, 12:00 PM - 1:30 PM Presentation Time: 1:00 PM Session date: Sunday, December 8, 2024 Presentation time: 6:00 PM - 8:00 PM Session date:...
PR Newswire
03/12/2024

Virbac: Türkiye: Virbac acquires its companion animal distributor

On December 2, we finalized the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion animal health products. Present in Türkiye for over 20 years via various local distributors, then with our own subsidiary since 2018, we are today taking a new step forward with the acquisition of our companion animal products distributor: Mopsan. Working alongside Turkish veterinarians for over 30 years, Mopsan has extensive experience in the petfood and companion...
Nasdaq GlobeNewswire
03/12/2024

Today Essity hosts its Capital Markets Day - Accelerating Profitable Growth

"We have raised our ambition with the new targets presented earlier this year. Today we will outline how we will accelerate profitable growth and continue to evolve towards our vision to be the undisputed global leader in hygiene and health. The event also gives an opportunity to meet some of the fantastic people working at Essity and visit the integrated production facility we have here in Valls," says Magnus Groth, President and CEO of Essity. "We have raised our ambition with…
PR Newswire
03/12/2024

Genethon and Hansa Biopharma announce initiation of a Phase 2 trial of…

Søren Tulstrup, President and CEO, Hansa Biopharma said, "We know that anti-AAV antibodies prevent up to 1 in 3 people from benefitting from gene therapies using AAV-vectors.1-4 That's why our collaboration with Genethon and the initiation of the Phase 2 clinical trial in Crigler-Najjar syndrome is so important. This collaboration with Genethon is the second of our three partnerships with leading gene therapy companies to have reached the clinical stage, marking an important milestone in…
PR Newswire
03/12/2024

Ipsen and Biomunex announce exclusive global licensing agreement for…

Ipsen secures exclusive global rights to develop, manufacture and commercialize BMX-502, a pre-clinical novel T cell engager (TCE) with first-in-class potentialBMX-502 is a bispecific antibody engaging MAIT cells, a subset of non-conventional T cells, and targeting the clinically validated tumor antigen GPC3 to kill cancer cells PARIS, FRANCE; 03 December 2024- Ipsen (Euronext: IPN; ADR: IPSEY) and Biomunex Pharmaceuticals today announced an exclusive global licensing agreement for BMX-502...
Nasdaq GlobeNewswire
03/12/2024

Valneva Reports Positive Three-Year Antibody Persistence Data for its…

Antibody levels remained high at 96% seroresponse in line with the two-year persistence data This long-lasting antibody persistence was comparable in older (65+) and younger adults Saint-Herblain (France), December 3, 2024– Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported positive antibody persistence data three years after vaccination with a single dose of its chikungunya vaccine IXCHIQ ®. The results are in line with Valneva's...
Nasdaq GlobeNewswire
03/12/2024

Neusoft Medical Systems Showcases AI-powered Medical Imaging Solutions at RSNA…

"At Neusoft Medical Systems, we empower radiologists to address clinical challenges while enhancing the accessibility and affordability of medical imaging for regions and communities in need," said Patrick Wu, CEO of Neusoft Medical Systems. "By integrating advanced medical imaging, artificial intelligence, and clinical expertise, we aim to provide caregivers with comprehensive tools for accurate diagnoses. We look forward to engaging with industry leaders at RSNA 2024 to further…
PR Newswire
03/12/2024

Drive Healthcare Innovation: Strategic KOL Profiling for Targeted Engagement and…

Key Opinion Leaders (KOLs) are essential in shaping healthcare strategies by offering insights that influence clinical decisions and treatment adoption. Engaging with KOLs early helps align therapies with patient needs and market trends. KOL profiling combines quantitative metrics like publications and clinical trial involvement with qualitative assessments to ensure companies engage the right experts. These efforts foster meaningful partnerships, driving clinical adoption and advocacy. Key...
PR Newswire
02/12/2024

Information regarding the total number of voting rights and  total number of…

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024 (Article 223-16 of the General Regulations of theAutorité des Marchés Financiers )Market : NYSE Euronext ParisISIN Code: FR 0010417345DateTotal number of shares Total number of voting rights 11/30/2024 102,847,501Total gross of voting rights: 102,847,501Total net* of voting rights: 102,582,335 * Net total =...
Nasdaq GlobeNewswire
02/12/2024

Small Molecule Drug Discovery Market Size to Hit USD 106.77 Billion by 2031 with…

The report from The Insight Partners lists several stakeholders—including pharmaceutical companies, CROs, and academic research institutions—along with valuable insights on how to successfully navigate this evolving market landscape and unlock new opportunities. The report from The Insight Partners lists several stakeholders—including pharmaceutical companies, CROs, and academic research institutions—along with valuable insights on how to successfully navigate this evolving market landscape…
PR Newswire
02/12/2024

Global Positive Airway Pressure Devices Market Size/Share Worth USD 10.54…

The positive airway pressure devices market comprises a vast array of products and services that are expected to register strength during the coming years. The report runs an in-depth analysis of market trends, key players, and future opportunities. The positive airway pressure devices market comprises a vast array of products and services that are expected to register strength during the coming years. The report runs an in-depth analysis of market trends, key players, and future…
PR Newswire
02/12/2024

Global Specialty Hospitals Market Size/Share Worth USD 1,361.21 billion by 2031…

The report from The Insight Partners provides several stakeholders—including service providers, physicians, patients, and end users—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. The report from The Insight Partners provides several stakeholders—including service providers, physicians, patients, and end users—with valuable insights into how to successfully navigate this evolving market landscape and unlock new…
PR Newswire
02/12/2024

Transpara Announces New FDA Clearance Designed to Improve Breast Cancer…

ScreenPoint will highlight its latest advancements, which include Transpara 2.1: an updated algorithm based on additional training and insights gathered from luminary users around the world. Transpara 2.1 is compatible with options for breast density (BIRADS and volumetric) and temporal comparison. Allowing suspicious areas on a current study to be analyzed against up to 3 priors over 6 years, the robust temporal comparison capability will be the first of its kind in the market. The Transpara…
PR Newswire
02/12/2024

Cosmetic Preservatives Market Size to Hit $846.44 Million, Globally at 4.6% CAGR…

The report from The Insight Partners, therefore, provides several stakeholders—including raw material suppliers, manufacturers, distributors, and others—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. The report from The Insight Partners, therefore, provides several stakeholders—including raw material suppliers, manufacturers, distributors, and others—with valuable insights into how to successfully navigate this evolving...
PR Newswire
02/12/2024

OSE Immunotherapeutics Strengthens Leadership and Executive Committee

OSE Immunotherapeutics Strengthens Leadership and Executive Committee NANTES, France, December 2, 2024 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced that it has strengthened the company's leadership and executive team with two new appointments.Fiona Olivierhas been appointed Chief Corporate Affairs and Investor Relations Officer and has joined the Executive Committee of OSE Immunotherapeutics.Aurore Morello,Head of Research and...
Nasdaq GlobeNewswire
02/12/2024

Microban Launches New Nature-Inspired Odor Control Technology

The new technology offers advanced performance by neutralizing a wide range of odors, keeping textiles fresher for longer. It meets GB/T 33610 and ISO 17299 testing standards for four of the most common odorants: isovaleric acid (IVA), acetic acid (HOAc), ammonia (NH3) and nonenal, making it a groundbreaking solution for tackling unpleasant smells. The new technology offers advanced performance by neutralizing a wide range of odors, keeping textiles fresher for longer. It meets GB/T 33610 and...
PR Newswire
02/12/2024

ReCerf® Hip Resurfacing Arthroplasty, from MatOrtho® Becomes the World's First…

"This is a monumental achievement not only for MatOrtho but for the field of orthopaedic surgery," said Oriol Millet-Lopez, Interim CEO at MatOrtho. "ReCerf represents the culmination of years of innovation and dedication to improving patient outcomes. TGA approval underscores the system's proven early performance and potential to redefine hip replacement globally." "This is a monumental achievement not only for MatOrtho but for the field of orthopaedic surgery,"…
PR Newswire
02/12/2024

AI in Precision Medicine Market to Hit US$ 3.92 Billion by 2030 with 30.7% CAGR…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153786351 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153786351 Browse in-depth TOC on "AI in Precision Medicine Market" 250 - Tables60 - Figures300 - Pages The rising shift towards integrating Al for drug discovery and development, diagnostic and screening and therapeutics augments the growth of the market. Al tools play a major role in precision...
PR Newswire
02/12/2024

Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

VANCOUVER, BC, Dec. 2, 2024 /PRNewswire/ -- USA News GroupNews Commentary – Despite death rates for some cancers being on the decline, there is a global surge in cancer cases among people under 50, with new cases up by 79% overall. Windpipe and prostate cancers are rising fastest, while breast, windpipe, lung, bowel, and stomach cancers have the highest death tolls. The United Nations projects cancer rates to increase by 77% by 2050. To combat this trend, researchers are advancing new therapies…
PR Newswire
02/12/2024

Global PPE Distribution Market to Hit USD 48.57 Billion by 2030, Driven by…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-27J5934/Global_Personal_Protective_Equipment_PPE_Distribution_Market Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-27J5934/Global_Personal_Protective_Equipment_PPE_Distribution_Market Major Factors Driving the Growth of Personal Protective Equipment (PPE) Distribution Market: The Personal Protective Equipment (PPE) distribution market is experiencing significant growth, driven by...
PR Newswire
02/12/2024

Blue Matter Hires New Partner, Deepak Veeraraghavan, Expanding Capabilities in…

"We are excited to bring Deepak on board," said Ashwin Dandekar, Managing Partner and CEO of Blue Matter. "Deepak will help advance our capabilities in decision science significantly, bringing a new level of rigor and sophistication, as well as the consistent use of best practices across all our teams globally." "We are excited to bring Deepak on board," saidAshwin Dandekar, Managing Partner and CEO of Blue Matter. "Deepak will help advance our capabilities in…
PR Newswire
02/12/2024

Canon Medical Informatics Selected by Leading U.S. Health System to Standardize…

"As healthcare organizations navigate an increasingly complex digital landscape, the demand for solutions that balance flexibility and control continues to grow," said Genady Knizhnik, Executive Vice President of Canon Medical Informatics. "By choosing to deploy Vitrea in a privately managed cloud environment, this health system demonstrates a strategic commitment to scalability and customization while maintaining the highest standards of data security and compliance. Canon's…
Nasdaq GlobeNewswire
02/12/2024
Altri  Comunicati